SCHEMBL296841

SCHEMBL296841

C=CC=CC=CCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17940495 1.00 TSHR (0.43)
SCHEMBL17940484 1.00 TSHR (0.43)
SCHEMBL296840 1.00
SCHEMBL17940488 1.00 TSHR (0.43)
SCHEMBL2827643 1.00 TSHR (0.43)
SCHEMBL17940486 1.00 TSHR (0.43)
SCHEMBL17940481 1.00 TSHR (0.43)
SCHEMBL19315864 1.00
SCHEMBL2827641 1.00 TSHR (0.43)
SCHEMBL17940487 1.00 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114793718-A Mating inhibitor for ectropis grisescens 安徽农业大学 2022-07-29 CN claimed
US-6720468-B2 BY REACTING WITH A DIELS-ALDER DIENOPHILE TO PROVIDE A FLUID COMPRISING A DIELS-ALDER ADDUCT AND MONOOLEFINS; AND RECOVERING A RESULTING MONOOLEFIN-CONTAINING FLUID CHEVRON PHILLIPS CHEMICAL COMPANY LP 2004-04-13 US claimed
US-20020165420-A1 Process for the removal of conjugated olefins from a monoolefin stream CHEVRON PHILLIPS CHEMICAL COMPANY LP 2002-11-07 US claimed
EP-0309340-B1 1,3,5-NONATRIENE DERIVATIVES, THEIR PREPARATION AND USE RHONE-POULENC SANTE (FR) 1991-05-29 EP claimed
US-4876370-A 1,3,5-nonatriene derivatives, their preparation and their use RHONE-POULENC SANTE (FR) 1989-10-24 US claimed
EP-0309340-A1 1,3,5-Nonatriene derivatives, their preparation and use RHONE-POULENC SANTE (FR) 1989-03-29 EP claimed
JP-1121231-A None JP disclosed
EP-3952858-B1 METHOD OF TREATING TUMOURS QBiotics Pty Ltd (AU) 2025-12-17 EP disclosed
US-20250368993-A1 Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof IONIS PHARMACEUTICALS, INC. (US) 2025-12-04 US disclosed
WO-2025231508-A1 DRILLING FLUID CONTAINING A CLAY/SHALE INHIBITOR, AND METHODS OF USING SAME Imdex Technologies Pty Ltd (AU) 2025-11-13 WO disclosed
WO-2025222234-A1 TARGETED DENDRIMER CONJUGATES STARPHARMA PTY LTD (AU) 2025-10-30 WO disclosed
US-12410116-B2 Compounds and use thereof in methods of treatment THE UNIVERSITY OF QUEENSLAND (AU) 2025-09-09 US disclosed
US-20250197417-A1 CRYSTALLINE INTERMEDIATES QBiotics Group Limited (AU) 2025-06-19 US disclosed
EP-0309340-B1 1,3,5-NONATRIENE DERIVATIVES, THEIR PREPARATION AND USE RHONE-POULENC SANTE (FR) 1991-05-29 EP disclosed
EP-0309340-B1 1,3,5-NONATRIENE DERIVATIVES, THEIR PREPARATION AND USE RHONE-POULENC SANTE (FR) 1991-05-29 EP disclosed
US-4876370-A 1,3,5-nonatriene derivatives, their preparation and their use RHONE-POULENC SANTE (FR) 1989-10-24 US disclosed
US-4876370-A 1,3,5-nonatriene derivatives, their preparation and their use RHONE-POULENC SANTE (FR) 1989-10-24 US disclosed
JP-H01121231-A 1,3,5-NONATRIENE DERIVATIVE, ITS PRODUCTION AND USE RHONE POULENC SANTE 1989-05-12 JP disclosed
EP-0309340-A1 1,3,5-Nonatriene derivatives, their preparation and use RHONE-POULENC SANTE (FR) 1989-03-29 EP disclosed
EP-0309340-A1 1,3,5-Nonatriene derivatives, their preparation and use RHONE-POULENC SANTE (FR) 1989-03-29 EP disclosed